The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series
2020-01-01 Stabile, A.; Orczyk, C.; Giganti, F.; Moschini, M.; Allen, C.; Punwani, S.; Cathala, N.; Ahmed, H. U.; Cathelineau, X.; Montorsi, F.; Emberton, M.; Briganti, A.; Sanchez-Salas, R.; Moore, C. M.
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)
2021-01-01 Foerster, B.; Abufaraj, M.; Mari, A.; Seisen, T.; Bandini, M.; Schweitzer, D.; Czech, A. K.; Moschini, M.; D'Andrea, D.; Bianchi, M.; Hendricksen, K.; Roupret, M.; Briganti, A.; van Rhijn, B. W. G.; Chlosta, P.; Colin, P.; John, H.; Shariat, S. F.
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration
2021-01-01 Afferi, L.; Zamboni, S.; Karnes, R. J.; Roghmann, F.; Sargos, P.; Montorsi, F.; Briganti, A.; Gallina, A.; Mattei, A.; Schulz, G. B.; Hendricksen, K.; Voskuilen, C. S.; Rink, M.; Poyet, C.; De Cobelli, O.; di Trapani, E.; Simeone, C.; Soligo, M.; Simone, G.; Tuderti, G.; Alvarez-Maestro, M.; Martinez-Pineiro, L.; Aziz, A.; Shariat, S. F.; Abufaraj, M.; Xylinas, E.; Moschini, M.
The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy
2020-01-01 Abufaraj, M.; Kimura, S.; Haitel, A.; Iwata, T.; Isleem, U.; D'Andrea, D.; Soria, F.; Mori, K.; Rink, M.; Bensalah, K.; Roupret, M.; Margulis, V.; Briganti, A.; Karakiewicz, P. I.; Shariat, S. F.
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder
2020-01-01 Luzzago, S.; Palumbo, C.; Rosiello, G.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; De Cobelli, O.; Karakiewicz, P. I.
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis
2021-01-01 Rosiello, G.; Palumbo, C.; Pecoraro, A.; Luzzago, S.; Deuker, M.; Stolzenbach, L. F.; Tian, Z.; Gallina, A.; Gandaglia, G.; Montorsi, F.; Shariat, S. F.; Saad, F.; Briganti, A.; Karakiewicz, P. I.
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer
2021-01-01 Wenzel, M.; Deuker, M.; Stolzenbach, F.; Nocera, L.; Colla Ruvolo, C.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Kluth, L. A.; Chun, F. K. H.; Karakiewicz, P. I.
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies
2020-01-01 Mazzone, E.; Mistretta, F. A.; Knipper, S.; Tian, Z.; Palumbo, C.; Gandaglia, G.; Fossati, N.; Shariat, S. F.; Saad, F.; Montorsi, F.; Graefen, M.; Briganti, A.; Karakiewicz, P. I.
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study
2021-01-01 Pecoraro, A.; Palumbo, C.; Knipper, S.; Mistretta, F. A.; Rosiello, G.; Tian, Z.; St-Hilaire, P. -A.; Shariat, S. F.; Saad, F.; Lavallee, L.; Briganti, A.; Kapoor, A.; Fiori, C.; Porpiglia, F.; Karakiewicz, P. I.
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis
2020-01-01 Knipper, S.; Palumbo, C.; Pecoraro, A.; Rosiello, G.; Tian, Z.; Briganti, A.; Zorn, K. C.; Saad, F.; Tilki, D.; Graefen, M.; Karakiewicz, P. I.
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder
2020-01-01 Luzzago, S.; Palumbo, C.; Rosiello, G.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I.
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities
2020-01-01 Luzzago, S.; Palumbo, C.; Rosiello, G.; Knipper, S.; Pecoraro, A.; Nazzani, S.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I.
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study
2020-01-01 Luzzago, S.; Palumbo, C.; Rosiello, G.; Knipper, S.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I.
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial
2020-01-01 Briganti, A.; Gandaglia, G.; Scuderi, S.; Gallina, A.; Colombo, R.; Fossati, N.; Barletta, F.; Pellegrino, A.; Nocera, L.; Montorsi, F.; Necchi, A.
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines
2020-01-01 Pecoraro, A.; Rosiello, G.; Luzzago, S.; Deuker, M.; Stolzenbach, F.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Kapoor, A.; Fiori, C.; Porpiglia, F.; Karakiewicz, P. I.
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis
2020-01-01 Mori, K.; Miura, N.; Mostafaei, H.; Quhal, F.; Sari Motlagh, R.; Pradere, B.; Kimura, S.; Kimura, T.; Egawa, S.; Briganti, A.; Karakiewicz, P. I.; Shariat, S. F.
Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661–9
2020-01-01 Bravi, C. A.; Montorsi, F.; Briganti, A.
Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733–41
2020-01-01 Gandaglia, G.; Montorsi, F.; Briganti, A.
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years
2020-01-01 Palumbo, C.; Pecoraro, A.; Rosiello, G.; Luzzago, S.; Deuker, M.; Stolzenbach, F.; Tian, Z.; Shariat, S. F.; Simeone, C.; Briganti, A.; Saad, F.; Berruti, A.; Antonelli, A.; Karakiewicz, P. I.
Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations
2020-01-01 Montorsi, F.; Bandini, M.; Briganti, A.; Dasgupta, P.; Gallina, A.; Gallucci, M.; Gill, I. S.; Guru, K. A.; Hemal, A.; Menon, M.; Moschini, M.; Murphy, D. G.; Parekh, D. J.; Patel, H. D.; Patel, H. R. H.; Stockle, M.; Tewari, A. K.; Wijburg, C. J.; Wiklund, P.; Wilson, T. G.; Mottrie, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series | 1-gen-2020 | Stabile, A.; Orczyk, C.; Giganti, F.; Moschini, M.; Allen, C.; Punwani, S.; Cathala, N.; Ahmed, H. U.; Cathelineau, X.; Montorsi, F.; Emberton, M.; Briganti, A.; Sanchez-Salas, R.; Moore, C. M. | |
| The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC) | 1-gen-2021 | Foerster, B.; Abufaraj, M.; Mari, A.; Seisen, T.; Bandini, M.; Schweitzer, D.; Czech, A. K.; Moschini, M.; D'Andrea, D.; Bianchi, M.; Hendricksen, K.; Roupret, M.; Briganti, A.; van Rhijn, B. W. G.; Chlosta, P.; Colin, P.; John, H.; Shariat, S. F. | |
| The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration | 1-gen-2021 | Afferi, L.; Zamboni, S.; Karnes, R. J.; Roghmann, F.; Sargos, P.; Montorsi, F.; Briganti, A.; Gallina, A.; Mattei, A.; Schulz, G. B.; Hendricksen, K.; Voskuilen, C. S.; Rink, M.; Poyet, C.; De Cobelli, O.; di Trapani, E.; Simeone, C.; Soligo, M.; Simone, G.; Tuderti, G.; Alvarez-Maestro, M.; Martinez-Pineiro, L.; Aziz, A.; Shariat, S. F.; Abufaraj, M.; Xylinas, E.; Moschini, M. | |
| The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy | 1-gen-2020 | Abufaraj, M.; Kimura, S.; Haitel, A.; Iwata, T.; Isleem, U.; D'Andrea, D.; Soria, F.; Mori, K.; Rink, M.; Bensalah, K.; Roupret, M.; Margulis, V.; Briganti, A.; Karakiewicz, P. I.; Shariat, S. F. | |
| The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder | 1-gen-2020 | Luzzago, S.; Palumbo, C.; Rosiello, G.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; De Cobelli, O.; Karakiewicz, P. I. | |
| The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis | 1-gen-2021 | Rosiello, G.; Palumbo, C.; Pecoraro, A.; Luzzago, S.; Deuker, M.; Stolzenbach, L. F.; Tian, Z.; Gallina, A.; Gandaglia, G.; Montorsi, F.; Shariat, S. F.; Saad, F.; Briganti, A.; Karakiewicz, P. I. | |
| The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer | 1-gen-2021 | Wenzel, M.; Deuker, M.; Stolzenbach, F.; Nocera, L.; Colla Ruvolo, C.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Kluth, L. A.; Chun, F. K. H.; Karakiewicz, P. I. | |
| Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies | 1-gen-2020 | Mazzone, E.; Mistretta, F. A.; Knipper, S.; Tian, Z.; Palumbo, C.; Gandaglia, G.; Fossati, N.; Shariat, S. F.; Saad, F.; Montorsi, F.; Graefen, M.; Briganti, A.; Karakiewicz, P. I. | |
| Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study | 1-gen-2021 | Pecoraro, A.; Palumbo, C.; Knipper, S.; Mistretta, F. A.; Rosiello, G.; Tian, Z.; St-Hilaire, P. -A.; Shariat, S. F.; Saad, F.; Lavallee, L.; Briganti, A.; Kapoor, A.; Fiori, C.; Porpiglia, F.; Karakiewicz, P. I. | |
| Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis | 1-gen-2020 | Knipper, S.; Palumbo, C.; Pecoraro, A.; Rosiello, G.; Tian, Z.; Briganti, A.; Zorn, K. C.; Saad, F.; Tilki, D.; Graefen, M.; Karakiewicz, P. I. | |
| Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder | 1-gen-2020 | Luzzago, S.; Palumbo, C.; Rosiello, G.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I. | |
| Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities | 1-gen-2020 | Luzzago, S.; Palumbo, C.; Rosiello, G.; Knipper, S.; Pecoraro, A.; Nazzani, S.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I. | |
| Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study | 1-gen-2020 | Luzzago, S.; Palumbo, C.; Rosiello, G.; Knipper, S.; Pecoraro, A.; Deuker, M.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I. | |
| Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial | 1-gen-2020 | Briganti, A.; Gandaglia, G.; Scuderi, S.; Gallina, A.; Colombo, R.; Fossati, N.; Barletta, F.; Pellegrino, A.; Nocera, L.; Montorsi, F.; Necchi, A. | |
| Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines | 1-gen-2020 | Pecoraro, A.; Rosiello, G.; Luzzago, S.; Deuker, M.; Stolzenbach, F.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Kapoor, A.; Fiori, C.; Porpiglia, F.; Karakiewicz, P. I. | |
| Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis | 1-gen-2020 | Mori, K.; Miura, N.; Mostafaei, H.; Quhal, F.; Sari Motlagh, R.; Pradere, B.; Kimura, S.; Kimura, T.; Egawa, S.; Briganti, A.; Karakiewicz, P. I.; Shariat, S. F. | |
| Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661–9 | 1-gen-2020 | Bravi, C. A.; Montorsi, F.; Briganti, A. | |
| Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733–41 | 1-gen-2020 | Gandaglia, G.; Montorsi, F.; Briganti, A. | |
| Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years | 1-gen-2020 | Palumbo, C.; Pecoraro, A.; Rosiello, G.; Luzzago, S.; Deuker, M.; Stolzenbach, F.; Tian, Z.; Shariat, S. F.; Simeone, C.; Briganti, A.; Saad, F.; Berruti, A.; Antonelli, A.; Karakiewicz, P. I. | |
| Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations | 1-gen-2020 | Montorsi, F.; Bandini, M.; Briganti, A.; Dasgupta, P.; Gallina, A.; Gallucci, M.; Gill, I. S.; Guru, K. A.; Hemal, A.; Menon, M.; Moschini, M.; Murphy, D. G.; Parekh, D. J.; Patel, H. D.; Patel, H. R. H.; Stockle, M.; Tewari, A. K.; Wijburg, C. J.; Wiklund, P.; Wilson, T. G.; Mottrie, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39411
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711498
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.771
- John Wiley and Sons Inc525
- Springer Science and Business Med...522
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer362
- MDPI347
- Elsevier Ltd330
- Springer Nature282
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28818
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33631
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1